PANACEABIOPharmaceuticals
Panacea Biotec Ltd — PE Ratio & Valuation Analysis
₹296.05
-2.65%
Current P/EN/AxPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E0.8x100.0% below avg
✅
100.0% Discount to Industry
PANACEABIO P/E N/Ax vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2022 | ₹176.05 | ₹142 | 0.8x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Panacea Biotec Ltd Valuation
Panacea Biotec Ltd (PANACEABIO) currently trades at N/Ax earnings. The Pharmaceuticals sector average PE is 31.77x. Historically, PANACEABIO has traded at an average PE of 0.8x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
-4.92%
Dividend Yield
0.00%
More on Panacea Biotec Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.